Adjuvant Imatinib treatment after R0 resection for patients with high-risk gastrointestinal stromal tumors: A median follow-up of 44 months
Wei-Zhong Jiang, Guo-Xian Guan, Hui-Shan Lu, Ying-Hong Yang, De-Yong Kang, He-Guang HuangVolume:
104
Year:
2011
Language:
english
Pages:
5
DOI:
10.1002/jso.22010
File:
PDF, 157 KB
english, 2011